Perspective Therapeutics (CATX) Total Liabilities (2016 - 2025)
Perspective Therapeutics (CATX) has disclosed Total Liabilities for 15 consecutive years, with $59.9 million as the latest value for Q4 2025.
- Quarterly Total Liabilities rose 18.85% to $59.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $59.9 million through Dec 2025, up 18.85% year-over-year, with the annual reading at $59.9 million for FY2025, 18.85% up from the prior year.
- Total Liabilities hit $59.9 million in Q4 2025 for Perspective Therapeutics, up from $52.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $62.7 million in Q3 2024 to a low of $2.9 million in Q4 2021.
- Historically, Total Liabilities has averaged $24.5 million across 5 years, with a median of $11.6 million in 2023.
- Biggest five-year swings in Total Liabilities: surged 558.51% in 2023 and later fell 16.07% in 2025.
- Year by year, Total Liabilities stood at $2.9 million in 2021, then increased by 20.55% to $3.4 million in 2022, then soared by 558.51% to $22.7 million in 2023, then surged by 122.05% to $50.4 million in 2024, then increased by 18.85% to $59.9 million in 2025.
- Business Quant data shows Total Liabilities for CATX at $59.9 million in Q4 2025, $52.6 million in Q3 2025, and $45.0 million in Q2 2025.